# Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients

> **NCT00627731** · PHASE4 · COMPLETED · sponsor: **Hamamatsu University** · enrollment: 50 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** methylprednisolone sodium succinate (mPSL)
- **DRUG:** prednisolone (PSL)

## Key facts

- **NCT ID:** NCT00627731
- **Lead sponsor:** Hamamatsu University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00627731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00627731, "Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00627731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*